SARS-CoV2 Infections in Heart Transplant Recipients: Vaccines Still Are Our Greatest Weapon.
Anno:
2024
Long-term clinical follow-ups are needed to assess the effectiveness of vaccine and booster doses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection for heart transplant (HT) recipients, particularly in an epidemiological landscape characterized by rapidly changing viral variants. Among patients who received HT at Niguarda Hospital from January…